The U.S. Food and Drug Administration (FDA) has approved for review a Biologics License Application (BLA) for AVT06, Alvotech ...

Clinical ink, a global life science technology company, is expanding its patient engagement solutions with the inclusion into its 21 CFR Part 11 platform of the SPURtm behavioral assessment tool and ...

Censoring research on how to deliver treatments to those most in need isn’t just nonsensical; it puts lives at risk and ...

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.

Use of a home-based electronic monitoring system for symptom reporting reduced ED visits among people receiving treatment for ...